AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bioworld Financial Watch articles from July 2005

3,200 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from Bioworld Financial Watch are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for Bioworld Financial Watch arrive.

Bioworld Financial Watch archives from July 2005

Finding post-IPO liquidity in an 'unpromised land'.
July 4, 2005... When Momenta Pharmaceuticals Inc. sought out the capital markets a year ago, the company priced its initial public offering significantly below the expected range. Here was a company barely 3 years old in a "post-bubble" financing...

10 biggest U.S. gainers for the week.
July 4, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Aeolus 69.64 CollaGenex 43.00 Neose Technol 40.50 Cardiovascular Biother 27.91 Cubist Pharma 22.02 Durect ...

10 biggest U.S. losers for the week.
July 4, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) MacroChem -22.58 Sirna Thera -18.14 Icoria -16.67 Novavax -16.41 NeoRx Corp. -16.22 CombiMatrix -14.83 InSite Vision -14.47...

Biotech mergers and acquisitions: April 1-June 30, 2005 (#).
July 4, 2005... Biotech Mergers And Acquisitions: April 1-June 30, 2005 (#) I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Date Acquired * Or Merged With * Announced Completed...

BioWorld stock report for public biotechnology companies.
July 4, 2005... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close Vol 6/24 7/1 ...

Novartis, Serono in MS race to market first oral therapy.(Tysabri Still Viable: Analyst)
July 11, 2005... Is everybody tired of hearing about Tysabri yet? The much-touted multiple sclerosis drug from Biogen Idec Inc., which pumped investors' hopes and then bombed, continues to grab headlines, albeit smaller ones. The drug was pulled from the...

10 biggest U.S. gainers for the week.
July 11, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) North Amer Scien 32.84 ViroPharma 30.94 Cardiovascular Bio 29.87 NeoRx Corp. 27.42 Auxilium 19.00 Transgenomic 18.57 Maxygen ...

10 biggest U.S. losers for the week.
July 11, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Biotime -33.33 Icoria -14.29 Helix Biomed -13.33 eXegenics -11.90 Matritech -11.43 Alliance -11.11 Access Pharma -10.93 Hana Bio ...

Public financing of biotechnology: June 2005.
July 11, 2005... I. COMMENCED TRADING IN JUNE Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units Out (M) (M)...

Other financings of public biotechnology companies: June 2005.
July 11, 2005... Other Financings Of Public Biotechnology Companies: June 2005 TOTAL: $1,796.73M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: June 2005.
July 11, 2005... I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $439.7M Company Location Date Amt. (M) AgraQuest Davis, Calif. 6/7/05 $14.35 Inc. AmpliMed Tucson, Ariz. 6/21/05 $5...

Money raised by biotech in 2005: January-June.
July 11, 2005... Money Raised By Biotech In 2005: January-June Type of Jan. Feb. March April financing Public offerings 585.7 799.4 303.9 71.2 Private biotechs 406.3 636.6 276.4 182.4...

BioWorld stock report for public biotechnology companies.
July 11, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 7/1 7/8 ...

Avanir, AstraZeneca: 'next step' in perpetual war on cholesterol.
July 18, 2005... In late December 2003, when Pfizer Inc. agreed to buy out Esperion Therapeutics Inc. for $1.3 billion-$35 per share, which amounted to a 54 percent premium to the average closing price during the previous 20 days--the pharmaceutical giant paid...

10 biggest U.S. gainers for the week.
July 18, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Momenta 51.51 Sirna Thera 44.97 Favrille 43.18 Kosan 34.73 XenoPort 25.53 StemCells 24.84 Santarus ...

10 biggest U.S. losers for the week.
July 18, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Argonaut -73.47 Immunicon -12.78 NeoRx Corp. -12.66 Ortec Int'l -12.50 Siga Technol -11.65 Epimmune -10.67 Hana Bio -10.00...

Clinical trials update: June 2005.
July 18, 2005... Clinical Trials Update: June 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Acorda Fampridine- Selective neuronal Therapeutics SR potassium channel...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: June 2005.
July 18, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: June 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab;...

FDA submissions, approvals and other actions: June 2005.
July 18, 2005... FDA Submissions, Approvals And Other Actions: June 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept; anti-tumor (AMGN) (FDA-approved)...

BioWorld stock report for public biotechnology companies.
July 18, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 7/8 7/15 WK YTD (000) Aastrom Biosci ASTM 3.26...

Analyst: Lucentis set to grab 'majority' of market for AMD.
July 25, 2005... Lucentis is on the march. Again. Last week, Genentech Inc. released the detailed data from the Phase III MARINA study of Lucentis (ranibizumab) in wet age-related macular degeneration, confirming interim data disclosed in May--but the news...

10 biggest U.S. gainers for the week.
July 25, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Hana Bio 41.98 Guilford Pharma 40.08 CancerVax 36.27 Alteon 33.33 Myogen 24.47 Alnylam 23.1 Aphton ...

10 biggest U.S. losers for the week.
July 25, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Neose Technol -22.88 Affymetrix -19.04 Northwest Bio 18.75 QLTPhotoTher -14.71 ViaCell -14.39 Momenta -13.44 Alliance -11.76...

U.S. public offerings by underwriter: Jan. 1-June 30, 2005 *.
July 25, 2005... U.S. Public Offerings By Underwriter: Jan. 1-June 30, 2005 * Underwriter Biotechnology Date Offering Company Priced Price Per (Symbol) ...

BioWorld stock report for public biotechnology companies.
July 25, 2005... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 7/15 7/22 WK YTD (000) Aastrom Biosci ASTM 3.2...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA